Mucopolysaccharidosis I, or MPS I, often presents initially as a child's failure to thrive, and is a diagnosis with devastating effects. How is new research able to help children with this lysosomal storage disorder? Host Dr. Bruce Bloom talks with Dr. David A. Pearce, director of the Sanford Children's Health Research Center in Sioux Falls, South Dakota, about advances in research into treatment options, including enzyme replacement therapy, for MPS I.
Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:
Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations
Immune System Irregularities in Lysosomal Storage Disorders
Long Term Efficacy and Safety of Laronidase for MPS I
